Delivery Order SPE2DB22D3401-SPE2DB24FT2VM
Award Date 4/29/24
Potential Completion Date 4/30/24
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,546.29, is a firm fixed-price delivery order for the supply of the vaccine ENGERIX-B 20 MCG/ML SYRNML. The contract has an ultimate completion date of May 1, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no mention of any subcontractors. The contract is not set aside...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the vaccine ENGERIX-B 20 MCG/ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,228.04 and a period of performance through May 23, 2024. The contract was awarded on a full and open competition basis without any set-aside designation. AmerisourceBergen, through its Corporate Office division, has significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of the vaccine ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML. The contract, valued at $2,620.20, is a firm fixed-price delivery order with a completion date of March 23, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered as a federal contractor. The contract does not have a set-aside...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,702.95 firm-fixed-price contract is for the delivery of the vaccine product ENGERIX-B 20 MCG/ML SYRNML. The contract has an ultimate completion date of July 1, 2025 and is not a set-aside award. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the ENGERIX-B 20 MCG/ML SYRNML vaccine. The $1,051.94 firm fixed price delivery order has a completion date of July 15, 2024. Amerisourcebergen, through its Corporate Office division, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, which serves as the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,771.30, is for the delivery of the vaccine product ENGERIX-B 20 MCG/ML SYRNML. The contract has a firm fixed price pricing type and is set to run through February 27, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
- This federal contract award, valued at $1,668.24, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of the ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine, with a completion date of December 18, 2024. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier. The $1,365.38 Firm Fixed Price Delivery Order is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has an ultimate completion date of April 24, 2024 and is not set aside for any specific business categories. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,890.02 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine products. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,560,287,421 units of the ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML vaccine. The $3,970.20 firm fixed-price delivery order has a completion date of March 17, 2023 and does not include any set-aside requirements. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...